{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 451307222
| IUPAC_name = 8-bromo-6-(''o''-chlorophenyl)-1-cyclohexyl-4''H''-5-triazolo(3,4-''c'')thieno(2,4-''e'')-1,4-diazepine
| image = Ciclotizolam structure.svg
| width = 145
| image2 = Ciclotizolam 3D ball.png
| width2 = 200
| alt2 = Ball-and-stick model of the ciclotizolam molecule

<!--Clinical data-->
| tradename =  
| legal_CA = Schedule IV
| legal_status =  

<!--Pharmacokinetic data-->
| bioavailability =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 58765-21-2
| ATC_prefix = none
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 2105986
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C20H18BrClN4S/c21-16-10-14-18(13-8-4-5-9-15(13)22)23-11-17-24-25-19(26(17)20(14)27-16)12-6-2-1-3-7-12/h4-5,8-10,12H,1-3,6-7,11H2
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = ZOSHXIXUCKESEG-UHFFFAOYSA-N
| PubChem = 71949
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 64956
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = JK517QTN4Q

<!--Chemical data-->
| C=20 | H=18 | Br=1 | Cl=1 | N=4 | S=1 
| molecular_weight = 461.806 g/mol
| smiles = Clc5ccccc5C/2=N/Cc1nnc(n1c3sc(Br)cc\23)C4CCCCC4
}}

'''Ciclotizolam'''<ref>DE Patent 2445430</ref> ('''WE-973''') is a drug which is a [[thienotriazolodiazepine]] derivative. It is a [[partial agonist]] for the benzodiazepine site of the [[GABAA receptor|GABA<sub>A</sub>]] [[Receptor (biochemistry)|receptor]], with similar [[Dissociation constant#Protein-ligand binding|binding affinity]] to related compounds like [[brotizolam]], but a low [[Intrinsic activity|efficacy]].<ref name="pmid2986988">{{cite journal |vauthors=Weber KH, Kuhn FJ, Böke-Kuhn K, Lehr E, Danneberg PB, Hommer D, Paul SM, Skolnick P |title=Pharmacological and neurochemical properties of 1,4-diazepines with two annelated heterocycles ('hetrazepines') |journal=European Journal of Pharmacology |volume=109 |issue=1 |pages=19–31 |date=February 1985 |pmid=2986988 |doi= 10.1016/0014-2999(85)90535-7|url=}}</ref><ref name="pmid2569655">{{cite journal |vauthors=Ikeda M, Weber KH, Bechtel WD, Malatynska E, Yamamura HI |title=Relative efficacies of 1,4-diazepines on GABA-stimulated chloride influx in rat brain vesicles |journal=Life Sciences |volume=45 |issue=4 |pages=349–58 |year=1989 |pmid=2569655 |doi= 10.1016/0024-3205(89)90145-8|url=}}</ref>

==See also==
*[[Benzodiazepine]]

==References==
<references/>

{{Benzodiazepines}}
{{GABAAR PAMs}}

[[Category:Benzodiazepines]]
[[Category:Chloroarenes]]
[[Category:GABAA receptor positive allosteric modulators]]
[[Category:Bromoarenes]]
[[Category:Thienotriazolodiazepines]]


{{sedative-stub}}